This company is no longer actively trading as an independent public company (delisted, acquired, or ceased operations). This profile is retained for reference.
M2Bio Sciences is a bioceutical company focused on alternative plant-based cannabinoids and mental health therapeutic research. M2Bio’s mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research, and emerging technologies. As one of a handful of companies in the world, M2Bio is actively researching the magic mushroom compound psilocybin by funding research at the University of Pretoria in South Africa. The exploratory research is aiming to discover novel indications for medical conditions such as depression, inflammation, and substance addiction.